A case-control study of polychlorinated biphenyl association with metabolic and hormonal outcomes in polycystic ovary syndrome

Edwina Brennan, Nitya Kumar, Daniel S. Drage, Thomas K. Cunningham, Thozhukat Sathyapalan, Jochen F. Mueller, Stephen L. Atkin

Research output: Contribution to journalArticlepeer-review

Abstract

Polychlorinated biphenyls (PCBs) are a class of environmental pollutants with a long half-life that sequester in fat. Women with polycystic ovarian syndrome (PCOS) may represent a sensitive subgroup to endogenous exposure to PCBs because of associated weight gain. Seven PCB congeners were compared in age, ethnicity, and BMI matched women with (n = 29) and without (n = 30) PCOS and related to metabolic outcomes, and steroid and thyroid hormone levels. PCB118, PCB138, PCB153, and PCB180 were detected in all serum samples but geometric mean did not differ between cases and controls. PCBs correlated with increasing concentrations of each other (p < .01), increasing age (p < .01) and decreasing lneGFR (p < .05). lnPCB118 correlated with increasing Free-T4 (p = .028). lnPCB158, lnPCB180, and ln∑PCB correlated with increasing lnSHBG (p = .044). In regression modeling, although not significant, PCB118 positively associated with lnSHBG in controls (p = .0504) but not in cases; estradiol inversely associated with PCB138 in controls (p = .055) and ∑PCB in cases (p = .051). No significant associations were observed between metabolic endpoints, and steroid and thyroid hormone levels. The results presented do not suggest the PCOS cases in this cohort are at adverse risk compared to age, ethnicity, and BMI matched controls.
Original languageEnglish
Pages (from-to)86-105
Number of pages20
JournalJournal of Environmental Science and Health, Part C
Volume40
Issue number1
DOIs
Publication statusPublished - 14 Mar 2022

Keywords

  • Polycystic ovarian syndrome
  • endocrine disrupters
  • polychlorinated biphenyls

Fingerprint

Dive into the research topics of 'A case-control study of polychlorinated biphenyl association with metabolic and hormonal outcomes in polycystic ovary syndrome'. Together they form a unique fingerprint.

Cite this